HOME >> MEDICINE >> NEWS
Starting beta-blocker before discharge in patients hospitalized for heart failure increases usage

CHICAGO -- Initiating low-dose beta-blockers prior to discharge in heart failure patients hospitalized for worsening symptoms significantly improves the use of a drug that has been shown in previous studies to reduce death and morbidity by more than 35 percent.

This finding is significant, said researchers from Duke University Medical Center and Northwestern University, because standard heart failure practice guidelines suggest waiting a period of two to four weeks after discharge prior to initiating beta-blocker therapy. This recommendation was based on a concern that beta-blocker initiation too soon after a hospitalization for heart failure may worsen heart failure symptoms, said the researchers.

Beta-blockers block the stimulatory effects of the neurohormones epinephrine and norepinephrine, the so-called "fight-or-flight" hormones. By blocking these hormones, beta-blockers reduce the stress on the heart and reverse myocardial remodeling. Most importantly, they have been shown to improve survival and reduce the need for hospitalization by 35 percent in several large-scale, prospective, randomized clinical trials. Despite these beneficial effects, it is estimated that nationally still only 30 to 40 percent of eligible patients receive beta-blocker therapy.

Such low usage led the researchers to initiate a trial to determine whether starting beta-blocker therapy in the hospital setting would improve usage. The results of that trial, reported today (Nov. 18, 2002) at the 75th annual scientific session of the American Heart Association, show that beginning beta-blocker therapy in-hospital can achieve a 91 percent usage rate 60 days after discharge.

"If we can dramatically improve the rate of beta-blocker usage by initiating therapy in-hospital, that would make a major impact these patients' lives," said Duke cardiologist Christopher O'Connor, M.D., who along with Duke's Wendy Gattis, Pharm.D., and Northwestern's Mihai Gheorghiade, M.D.,
'"/>

Contact: Richard Merritt
merri006@mc.duke.edu
919-684-4148
Duke University Medical Center
18-Nov-2002


Page: 1 2 3 4

Related medicine news :

1. Starting dose of Lexapro as effective as optimally dosed Zoloft in the treatment of depression
2. In heart failure, beta-blockers boost survival advantage for women
3. NHLBI-VA study finds no increased survival from beta-blocker for moderate to advanced heart failure
4. Wider use of beta-blockers after heart attacks could save thousands of lives at a reasonable cost, new study shows
5. Selective and nonselective beta-blockers equally effective in preventing sudden death
6. Ethical discussion should come before research
7. Stroke warning signs often occur hours or days before attack
8. Diffusion-weighted MRI can diagnose mad cow-related disease in humans before symptoms show
9. Study shows drugs such as Vioxx and Celebrex were widely over-used long before recent problems
10. Newborns with heart defect have low blood flow in brain before surgery
11. Drug companies should disclose adverse events before licensing

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... ... While it’s often important to take certain medications during the night, finding them ... a solution. , She developed a prototype for MOTION LIGHT-UP PILL BOX to provide ... need to turn on a light when taking medication during the night, allowing the ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the Law ... organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps our ... a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual ... in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon ... fun run is geared towards children of all ages; it is a non-competitive, non-timed ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and ... of published author, William Nowers. Captain Nowers and his wife, Millie, have six ... years in the Navy. Following his career as a naval aviator and carrier ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), ... of an innovative new design of the shoulder pad. The shoulder pad provides ... while controlling your pain while using cold therapy. By utilizing ice and water that ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... Sept. 25, 2017   Montrium , an ... solutions, today—from the IQPC Trial Master Files & ... NL)—announced that EastHORN Clinical Services has selected ... and TMF management. EastHORN, a leading European contract ... to increase transparency to enable greater collaboration with ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/22/2017)... Sept. 22, 2017 AVACEN Medical (AVACEN) announced ... now successfully helping those with the widespread pain associated ... diagnosed Amanda in Essex, England ... my hair, experiencing no sleep at all, tremendous pain, ... I cannot recommend [the AVACEN 100] enough, how this ...
Breaking Medicine Technology:
Cached News: